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of proinflammatory cytokine production. As CVVH only tran-Tumor necrosis factor-a during continuous high-flux hemodial-
siently improves TNF-a production, it is most likely that theysis in sepsis with acute renal failure. Suppressed ex vivo endo-
putative suppressing factor is removed because of saturabletoxin (ET)-induced production of the proinflammatory cyto-
membrane adsorption in CVVH. In CHFD, there is a combina-kine, tumor necrosis factor-a (TNF-a), in isolated mononuclear
tion of adsorption and detectable diffusion into the dialysate.cells (PBMCs) is associated with fatal outcome in severe sepsis.
PBMCs from surviving patients, but not those from nonsurviv- It remains to be shown whether a further increase in the volume
ing patients, recover their capacity to produce normal amounts of dialysate per day is able to not only improve but normalize
of TNF-a. We tested the influence of two modalities of continu- the cytokine response and improve outcome in septic patients
ous renal replacement therapy (CRRT) on ex vivo-induced with acute renal failure.
whole-blood production of TNF-a and inhibitory TNF-soluble
receptor type I (TNFsRI) in 12 patients with acute renal failure
and sepsis (APACHE II score 22 to 30).
Multiple organ dysfunction syndrome (MODS) is theMethods. Standard continuous venovenous hemofiltration
(CVVH; 36 liters of bicarbonate substitution fluid per day) most common cause of acute renal failure in the intensive
was performed in 7 patients using polyamid hemofilters (FH66; care unit today. There is no doubt that proinflammatory
Gambro). In an additional five patients, we performed daily cytokines such as tumor necrosis factor-a (TNF-a) and
18 hours of high-flux hemodialysis (CHFD) using polysulfon
interleukin (IL)-1b play an important role in the induc-F60S dialyzers (Fresenius) and 75 liters of bicarbonate dialysate
tion and continuation of severe disturbances in patientsusing the GENIUSt single-pass batch dialysis system. Samples
were separated from the blood circuit as well as from the suffering from sepsis. However, there is no correlation
ultrafiltrate/spent dialysate lines at the start, during, and end between plasma levels of TNF-a, IL-1b, and IL-6 and
of treatment. Whole-blood samples were incubated with 1 the degree of activation of circulating mononuclear cellsng/ml of ET for three hours at 378C. Ultrafiltrate or dialysate
(PBMCs), as indicated by the cell-associated concentra-samples were incubated with donor whole blood in the pres-
ence of ET to measure suppressing activity in ultrafiltrate and tions of the same cytokines in PBMCs during sepsis [1].
spent dialysate. In contrast to cytokine plasma levels, which are generally
Results. At the start of CRRT, ET-induced whole-blood elevated in septic patients, it has been shown that cell-
TNF-a production was suppressed to approximately 10% of
associated cytokines in PBMCs may be decreased andthat in normal controls. During CVVH, median ET-induced
that the capacity of PBMCs to produce TNF-a and IL-1bTNF-a production increased from 0.35 ng/ml at the start to 1.2
ng/ml at three hours, but decreased to pre-CVVH levels at the in response to endotoxin (ET) in vitro is significantly
end of a 24-hour period. In contrast, in patients on CHFD, the reduced, particularly in patients with gram-negative sep-
median ET-induced TNF-a production was 0.5 ng/ml at the sis [2, 3]. Astiz et al showed that the reduced capacity ofstart, 1.1 ng/ml at 3 hours, 1.6 ng/ml at six hours, and 1.5 ng/ml
PBMC production of proinflammatory cytokines was as-at the end of 18 hours of treatment. The ultrafiltrate obtained
sociated with increased plasma levels of IL-10 and pros-after three hours of CVVH did not contain suppressing activity.
In CHFD, the spent dialysate as compared with fresh dialysate taglandin E2, which are known to inhibit the production
suppressed ET-induced TNF-a production in donor blood by of proinflammatory cytokines [3]. The authors concluded
33% throughout the 18 hours of treatment. Whole-blood pro-
that in severe sepsis, there may be a hyporesponsivenessduction of TNFsRI did not change significantly at any time
of PBMCs because of an overproduction of anti-inflam-point during CVVH or CHFD.
Conclusion. These data suggest that high-volume CHFD is matory cytokines. Munoz et al demonstrated that PBMCs
superior to standard CVVH in removing a suppressing factor from surviving patients, but not those from nonsurviving
patients, recover their capacity to produce normal amounts
of TNF-a and IL-1b [2]. It may be concluded from theseKey words: renal replacement therapy, cytokines, nephrotoxicity, sep-
sis, acute renal failure, MODS. data that interventions that are able to improve the ca-
pacity of PBMCs to produce proinflammatory cytokines 1999 by the International Society of Nephrology
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could be beneficial with respect to the outcome in pa- RESULTS
tients suffering from severe sepsis. We investigated the Ex vivo ET-induced whole-blood production of TNF-a
effect of two modalities of continuous renal replacement was significantly suppressed in patients with acute renal
therapy (CRRT) on ex vivo ET-induced cytokine produc- failure and sepsis (N 5 10) compared with blood samples
tion in patients with acute renal failure caused by MODS. from healthy controls (N 5 18; Fig. 1). The median values
were 500 pg/ml in patients and 7100 pg/ml in controls.
In contrast, the production of the anti-inflammatory cy-METHODS
tokine IL-10 was slightly increased in whole-blood sam-Twelve patients (8 men and 4 women) in the intensive
ples of patients compared with controls (Fig. 1).care unit, all on mechanical ventilation and with acute
During CVVH, suppressed ET-induced TNF-a pro-renal failure in the course of MODS, were studied. The
duction improved transiently from a median value ofunderlying diseases included pancreatitis, esophagus car-
0.34 ng/ml (range 0.23 to 0.72) at 5 minutes to 1.2 ng/mlcinoma, pneumonia, bowel obstruction with perforation,
(0.55 to 1.40) after 3 hours and returned to 0.51 ng/mlendocarditis, and liver failure. The APACHE II score
(0.34 to 1.09) after 24 hours (Fig. 2). During CHFD,was 22 to 30 in all patients.
TNF-a production improved continuously from 0.49
Group A ng/ml (0.10 to 1.80) at 5 minutes to 1.1 ng/ml (0.23 to
In seven patients (5 men and 2 women), continuous 2.3) at 3 hours, to 1.59 (0.49 to 2.8) at 6 hours, and to
venovenous hemofiltration (CVVH) was performed us- 1.52 ng/ml (0.76 to 2.42) at 18 hours (Fig. 2). In contrast,
ing polyamide ultrafilters (FH66; Gambro), bicarbonate- ET-induced whole-blood production of the inhibitory
buffered substitution fluid, a blood flow of 100 ml/min, soluble TNF receptor type I (TNFsRI) did not change.
and an ultrafiltration rate of 25 ml/min (equal to 1500 During CVVH, TNFsRI production was 9.0 ng/ml (4.3
ml/hr and 36 liter/day). Samples were taken from the to 11.3) at 5 minutes, 8.0 ng/ml (4.03 to 12.0) at 3 hours,
afferent blood line of the extracorporeal circuit as well and after 24 hours, it was 8.5 ng/ml (6.4 to 11.6). During
as from the ultrafiltrate line 5 minutes, 3 hours, and 24 CHFD, ET-induced whole blood production of TNFsRI
hours after a new filter was connected. was 8.0 ng/ml (4.4 to 12) at five minutes, 8.8 ng/ml (4.1
to 11.6) at 3 hours, 9.0 ng/ml (3.7 to 12.8) at 6 hours,Group B
and 7.8 ng/ml (3.7 to 11.0) after 18 hours (Fig. 3).
In five patients (3 men and 2 women), continuous high- Compared with isotonic saline as the control, the ultra-
flux hemodialysis (CHFD) was performed with polysulfone filtrate samples obtained after five minutes and three
dialyzers (F60S; Fresenius) and acetate-free bicarbonate- hours of CVVH did not significantly suppress ET-induced
buffered dialysate using the GENIUSt single-pass batch TNF-a production in donor blood. In contrast, spent
hemodialysis system. In this system, 75 liters of sterile
dialysate compared with fresh dialysate suppressed
dialysate were recirculated single pass in a closed loop
TNF-a production in donor blood by 33 6 7% through-dialysate circuit. Blood flow was 70 ml/min and equal to
out the 18 hours of CHFD.a countercurrent dialysate flow of 70 ml/min (4200 ml/hr,
75 liter/18 hr). Samples were taken from the afferent
blood line as well as from the fresh and the spent dialy- DISCUSSION
sate lines at 5 minutes, 3 hours, 6 hours, and 18 hours
Our data confirm previous publications describing se-
of CHFD.
vere suppression of the production of proinflammatoryWhole-blood samples (1 ml) were incubated with equal
cytokines in circulating mononuclear cells during sepsisamounts of cell culture medium (RPMI) containing 1 ng/ml
[2, 3]. In addition, we show that the synthesis of proin-of ET (final concentration) for three hours at 378C in
flammatory cytokines, but not that of anti-inflammatorypyrogen-free polypropylene tubes. Following incubation,
cytokines, is suppressed. The data for TNF-a and TNFsRItubes were centrifuged, and whole-blood culture super-
production are shown, and similar results were obtainednatants were separated to measure cytokines [TNF-a,
for proinflammatory IL-1b, which was suppressed, andTNF-soluble receptor type I (TNFsRI), IL-10] using spe-
inhibitory IL-1 receptor antagonist, which was not sup-cific immunoassays.
pressed. Also, plasma levels of IL-10 as well as ET-In addition, ultrafiltrate samples in CVVH and dialy-
induced whole-blood production of IL-10 did not changesate samples (fresh and spent) in CHFD were incubated
during CVVH or CHFD (data not shown). We concludewith donor blood in the presence of 1 ng/ml ET for three
that CRRT exclusively modifies the capacity of circulat-hours at 378C in order to test for suppressing activity of
ing cells to produce proinflammatory cytokines withoutET-induced whole blood cytokine production. TNF-a
influencing the synthesis of anti-inflammatory mediatorswas measured by specific immunoassays in whole blood
culture supernatants. in patients with severe sepsis. Standard CVVH with a
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Fig. 1. Endotoxin-induced whole blood pro-
duction of tumor necrosis factor-alpha (A;
TNF-a) and interleukin-10 (B; IL-10) in
healthy controls (N 5 18) and patients with
sepsis and acute renal failure.
Fig. 2. Effect of continuous venovenous hemofiltration (j; CVVH, 1.5 Fig. 3. Effect of CVVH (j; 1.5 liters/hr) and GENIUSt-CHFD (d;liters/hr) and continuous high flux hemodialysis (d; GENIUSt-CHFD, 4.2 liters/hr) on ex vivo whole-blood production of inhibitory soluble4.2 liters/hr) on ex vivo whole-blood TNF-a production in septic patients TNF receptor type I (TNFsRI) in septic patients with acute renal failure.with acute renal failure. Symbols indicate the medians of N 5 7 for Symbols indicate the medians of N 5 7 for CVVH and N 5 5 forCVVH and N 5 5 for CHFD. CHFD.
been described for circulating cytokines such as IL-1bpolyamid membrane and 36 liters of fluid exchange (ultra-
filtration vs. substitution) transiently improves suppressed and TNF-a [4, 5] and for complement components such
as factor D [6].production of TNF-a by approximately 300% after three
hours of treatment with a new filter. At the end of a 24- Improvement of suppressed whole blood production
of TNF-a was more effective during high-flux hemodialy-hour treatment, suppression was as severe as at the start
of a new filter for CVVH. The ultrafiltrate did not contain sis using the GENIUSt system. In this system, dialysate
circulates in a closed loop connected to a 75 liter tanksignificant amounts of suppressing activity, suggesting
that the putative suppressing factor is not removed by in which the pressure is slightly positive. Therefore, the
mechanism of solute transport across the high-flux mem-filtration. The most plausible explanation for the im-
proved production of ET-induced TNF-a production brane is not only diffusion but also filtration combined
with backfiltration. During GENIUSt-CHFD, suppressedafter three hours of CVVH is adsorption of the sup-
pressing factor to the filter membrane. As adsorption is TNF-a synthesis is improved within the first three hours.
It continues to increase until a plateau is reached at sixsaturable, removal is limited, and suppression increases
again. Removal by saturable adsorption has previously hours, which lasts until the end of the 18-hour treatment.
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In parallel to improved TNF-a production in whole cytokines may be useful to monitor the effect of CRRT
(particularly high-volume CVVH or CHFD) in the treat-blood, suppressing activity appeared in spent dialysate,
ment of MODS.indicating that during CHFD with polysulfon F60S, a
soluble suppressing factor is removed by diffusion and/ Reprint requests to Gerhard Lonnemann, M.D., Gemeinschaftspraxis
or filtration. An additional effect caused by adsorption Nephrologie/Dialyze, Eickenhof 15, 30851 Langenhagen, Germany.
E-mail: GLonnemann@T-online.deto the dialyzer membrane is possible. Although TNF-a
production in septic patients improves significantly dur-
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